OA-11 Utility of 18FDG-PET/CT for risk prediction in relapsed/refractory multiple myeloma patients undergoing CAR-T cell therapy: analysis of baseline and early assessment scans after one and three months
Clinical Lymphoma, Myeloma & Leukemia(2023)
关键词
relapsed/refractory multiple myeloma patients,multiple myeloma,fdg-pet
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要